Negative conversion of high serum p53 antibody titers in a patient with gastric cancer at 31 months after surgery

Clin J Gastroenterol. 2017 Aug;10(4):357-360. doi: 10.1007/s12328-017-0749-9. Epub 2017 May 24.

Abstract

We performed distal gastrectomy with D2 lymph node dissection, pathological stage was Stage IB (T2N0M0), in a 68-year-old male with gastric adenocarcinoma. We then monitored serum p53 antibody titers for 5 years and found it consistently decreased, without disease recurrence. Although the s-p53-Ab titer remained positive even after 2 years, it decreased to 16.5, 4.45, 2.66, 1.55, and 1.18 U/ml at 3 months, 7 months, 1 year, 2 years and 3 years after surgery, respectively. The s-p53-Ab titer finally converted from positive to negative at 31 months postoperatively without any sign of recurrence by computed tomography examination at 5 years after surgery. This case report shows that the changing pattern of s-p53-Ab titer after surgery may be useful to identify patients without recurrence. Further studies are required to gain a more precise understanding of the clinical impact of s-p53-Ab titer monitoring in gastric adenocarcinoma.

Keywords: Gastric cancer; Long-term monitoring; Postoperative; Recurrence; Serum p53 antibody.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / blood*
  • Adenocarcinoma / surgery
  • Aged
  • Humans
  • Long-Term Care
  • Lymph Node Excision
  • Male
  • Neoplasm Recurrence, Local / diagnosis
  • Postoperative Care
  • Stomach Neoplasms / blood*
  • Stomach Neoplasms / surgery
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Tumor Suppressor Protein p53